SCHEMBL6359867

SCHEMBL6359867

CCC(C)NC(=O)CC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.45
MMP2 P08253 1/20 0.45
MMP3 P08254 1/20 0.45
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
PKM P14618 1/20 0.41
ALPL P05186 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 3/20 0.40
KMT2A Q03164 3/20 0.40
HPGD P15428 1/20 0.39
MEN1 O00255 2/20 0.38
EPHX1 P07099 1/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4C Q9H3R0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23975222 0.83 MMP1 (0.42) MMP1MMP2MMP3CA12CA1
SCHEMBL22820158 0.83 CNR2 (0.39) SMN1; SMN2HTTKMT2AMEN1ALDH1A1
SCHEMBL22280301 0.81 PIK3CD (0.40) CA1CA2SMN1; SMN2GAAHTT
SCHEMBL14241693 0.81 SMN1; SMN2 (0.44) MMP1MMP2MMP3CA12CA1
SCHEMBL19200100 0.81 SMN1; SMN2 (0.44) MMP1MMP2MMP3CA12CA1
SCHEMBL13253317 0.81 MLYCD (0.40) MMP1MMP2MMP3SMN1; SMN2HTT
SCHEMBL7890623 0.79 MEN1 (0.43) MMP1MMP2CA12CA1CA2
SCHEMBL18946428 0.79 SMN1; SMN2 (0.46) MMP1MMP2MMP3CA12CA1
SCHEMBL16730101 0.78 LMNA (0.41) SMN1; SMN2HTTL3MBTL1KDM4EKMT2A
SCHEMBL21307515 0.77 POLB (0.37) CA1CA2SMN1; SMN2PKML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3497094-B1 TLR7/8 ANTAGONISTS AND USES THEREOF MERCK PATENT GMBH (DE) 2023-02-15 EP disclosed
US-8168654-B2 Quinuclidine derivatives binding to mucarinic M3 receptors NOVARTIS AG (CH) 2012-05-01 US disclosed